216 related articles for article (PubMed ID: 35363819)
21. Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors.
Pujadas E; Chen L; Rodriguez FJ
Brain Tumor Pathol; 2019 Apr; 36(2):40-51. PubMed ID: 30859342
[TBL] [Abstract][Full Text] [Related]
22. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
[TBL] [Abstract][Full Text] [Related]
23. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
[TBL] [Abstract][Full Text] [Related]
24. The involvement of the MAPK pathway in pilocytic astrocytomas.
Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
[TBL] [Abstract][Full Text] [Related]
25. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
26. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
[TBL] [Abstract][Full Text] [Related]
27. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
28. A high-grade glioma with
Vidal B; Bryke C; Hsu N; Alterman R; Yeo AT; Charest A; Varma H
Clin Neuropathol; 2020; 39(3):126-134. PubMed ID: 31841105
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
30. New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.
Karsy M; Guan J; Cohen AL; Jensen RL; Colman H
Curr Neurol Neurosci Rep; 2017 Feb; 17(2):19. PubMed ID: 28271343
[TBL] [Abstract][Full Text] [Related]
31. Pilocytic astrocytoma in adults: Histopathological, immunohistochemical and molecular study with clinical association.
Salles D; Santino SF; Diana P; Malinverni ACM; Stávale JN
Pathol Res Pract; 2023 Dec; 252():154942. PubMed ID: 37984046
[TBL] [Abstract][Full Text] [Related]
32. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.
Rudà R; Capper D; Waldman AD; Pallud J; Minniti G; Kaley TJ; Bouffet E; Tabatabai G; Aronica E; Jakola AS; Pfister SM; Schiff D; Lassman AB; Solomon DA; Soffietti R; Weller M; Preusser M; Idbaih A; Wen PY; van den Bent MJ
Neuro Oncol; 2022 Dec; 24(12):2015-2034. PubMed ID: 35908833
[TBL] [Abstract][Full Text] [Related]
33. H3K27M mutant glioma: Disease definition and biological underpinnings.
Saratsis AM; Knowles T; Petrovic A; Nazarian J
Neuro Oncol; 2024 May; 26(Supplement_2):S92-S100. PubMed ID: 37818718
[TBL] [Abstract][Full Text] [Related]
34. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
[TBL] [Abstract][Full Text] [Related]
35. BRAF V600E mutation and 9p21: CDKN2A/B and MTAP co-deletions - Markers in the clinical stratification of pediatric gliomas.
Frazão L; do Carmo Martins M; Nunes VM; Pimentel J; Faria C; Miguéns J; Sagarribay A; Matos M; Salgado D; Nunes S; Mafra M; Roque L
BMC Cancer; 2018 Dec; 18(1):1259. PubMed ID: 30558563
[TBL] [Abstract][Full Text] [Related]
36. Diencephalic pediatric low-grade glioma harboring the BRAF V600E mutation presenting with various morphologies in sequential biopsy specimens.
Ishi Y; Hatanaka KC; Yamaguchi S; Fujita H; Motegi H; Kobayashi H; Terasaka S; Houkin K
Brain Tumor Pathol; 2017 Oct; 34(4):165-171. PubMed ID: 28836232
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.
Kai Z; Dingyang L; Zhuanyi Y
World Neurosurg; 2021 Mar; 147():42-46. PubMed ID: 33316486
[TBL] [Abstract][Full Text] [Related]
38. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
39. [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification].
Figarella-Branger D; Chappe C; Padovani L; Mercurio S; Colin C; Forest F; Bouvier C
Bull Cancer; 2013; 100(7-8):715-26. PubMed ID: 23831947
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.
Roth JJ; Santi M; Rorke-Adams LB; Harding BN; Busse TM; Tooke LS; Biegel JA
Cancer Genet; 2014 Apr; 207(4):111-23. PubMed ID: 24767714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
